{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T11:19:01Z","timestamp":1753183141169},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"unrestricted grant from Medice, Iserlohn Germany"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jpba.2019.06.008","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T08:58:19Z","timestamp":1561107499000},"page":"578-587","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A validated LC\u2013MS\/MS method for the determination of homocysteic acid in biological samples"],"prefix":"10.1016","volume":"174","author":[{"given":"R.","family":"Gurke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.C.","family":"Fleck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Geisslinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Ferreir\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2019.06.008_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.envpol.2015.04.021","article-title":"Comprehensive evaluation of pharmaceuticals and personal care products (PPCPs) in typical highly urbanized regions across China","volume":"204","author":"Wang","year":"2015","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.jpba.2019.06.008_bib0010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neubiorev.2016.08.014","article-title":"Homocysteine and cognition: a systematic review of 111 studies","volume":"69","author":"Seti\u00e9n-Suero","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpba.2019.06.008_bib0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mam.2016.11.003","article-title":"Homocysteine and disease: Causal associations or epiphenomenons?","volume":"53","author":"Hannibal","year":"2017","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.jpba.2019.06.008_bib0020","first-page":"1","article-title":"Epigenetic factors in late-onset alzheimer\u2019s disease : MTHFR and CTH gene polymorphisms, metabolic transsulfuration and methylation pathways, and B vitamins","volume":"319","author":"Rom\u00e1n","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2019.06.008_bib0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/187152711794653797","article-title":"Homocysteine in neurological disease: a marker or a cause?","volume":"10","author":"Khanna","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets."},{"key":"10.1016\/j.jpba.2019.06.008_bib0030","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.tips.2011.05.003","article-title":"Is hyperhomocysteinemia an Alzheimer\u2019s disease (AD) risk factor, an AD marker, or neither?","volume":"32","author":"Zhuo","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jpba.2019.06.008_bib0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0006-8993(87)91531-9","article-title":"l-Homocysteate is a potent neurotoxin on cultured cortical neurons","volume":"437","author":"Kim","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.jpba.2019.06.008_bib0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jns.2003.11.009","article-title":"Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity","volume":"218","author":"G\u00f6rtz","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jpba.2019.06.008_bib0045","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbadis.2015.11.015","article-title":"Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID)","volume":"1862","author":"Hainsworth","year":"2016","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.jpba.2019.06.008_bib0050","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.lfs.2005.02.014","article-title":"Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"77","author":"Isobe","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.jpba.2019.06.008_bib0055","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jnr.20514","article-title":"Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer\u2019s disease","volume":"80","author":"Hasegawa","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jpba.2019.06.008_bib0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2012-120022","article-title":"Urinary homocysteic acid levels correlate with mini-mental state examination scores in Alzheimer\u2019s disease patients","volume":"31","author":"Hasegawa","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpba.2019.06.008_bib0065","doi-asserted-by":"crossref","first-page":"e8593","DOI":"10.1371\/journal.pone.0008593","article-title":"Treatment of alzheimer\u2019s disease with anti-homocysteic acid antibody in 3xTg-AD male mice","volume":"5","author":"Hasegawa","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2019.06.008_bib0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/abio.1994.1335","article-title":"Measurement of excitatory sulfur amino acids, cysteine sulfinic acid, cysteic acid, homocysteine sulfinic acid, and homocysteic acid in serum by stable isotope dilution gas chromatography-mass spectrometry and selected ion monitoring","volume":"220","author":"Santhosh-Kumar","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jpba.2019.06.008_bib0075","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1200\/JCO.1997.15.8.2800","article-title":"Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer","volume":"15","author":"Quinn","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jpba.2019.06.008_bib0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.chroma.2016.04.006","article-title":"Benzoyl chloride derivatization with liquid chromatography\u2013mass spectrometry for targeted metabolomics of neurochemicals in biological samples","volume":"1446","author":"Wong","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2019.06.008_bib0085","article-title":"High-throughput and simultaneous quantitative analysis of homocysteine\u2013methionine cycle metabolites and co-factors in blood plasma and cerebrospinal fluid by isotope dilution LC\u2013MS\/MS","author":"Guiraud","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2019.06.008_bib0090","doi-asserted-by":"crossref","first-page":"11737","DOI":"10.1021\/acs.analchem.7b03232","article-title":"Identification of metabolite biomarkers for gout using capillary ion chromatography with mass spectrometry","volume":"89","author":"Cui","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2019.06.008_bib0095","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3892\/ol.2014.2214","article-title":"Differential levels of L-homocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancer","volume":"8","author":"Kim","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jpba.2019.06.008_bib0100","series-title":"Guidance for Industry: Bioanalytical Method Validation","year":"2001"},{"key":"10.1016\/j.jpba.2019.06.008_bib0105","first-page":"1","volume":"vol. 44","year":"2012"},{"key":"10.1016\/j.jpba.2019.06.008_bib0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/18746098112059990007","article-title":"Why is homocysteine toxic for the nervous and immune systems?","volume":"6","author":"Boldyrev","year":"2013","journal-title":"Curr. Aging Sci."},{"key":"10.1016\/j.jpba.2019.06.008_bib0115","doi-asserted-by":"crossref","first-page":"1281S","DOI":"10.1093\/jn\/126.suppl_4.1281S","article-title":"Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status\u2014a possible element of the extracellular antioxidant defense system","volume":"126","author":"Ueland","year":"1996","journal-title":"J. Nutr."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519306260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519306260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T20:55:46Z","timestamp":1564174546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708519306260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":23,"alternative-id":["S0731708519306260"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2019.06.008","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A validated LC\u2013MS\/MS method for the determination of homocysteic acid in biological samples","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2019.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}